Gut Microbiome Could Play Role in MS
MONDAY, Sept. 26, 2022 (HealthDay News) — Scientists have been looking to the microbiome, and its numerous gut bacteria, as an area of research with plenty of potential for finding connections to various diseases.Now, scientists have found evidence o…
Learn MoreLupus, MS and Other Autoimmune Disorders Raise Heart Risks
WEDNESDAY, Aug. 31, 2022 (HealthDay News) — Research has linked heart disease to specific autoimmune diseases such as rheumatoid arthritis and lupus. Now, a huge study shows that autoimmune diseases as a group increase your chances of developing hear…
Learn MoreUblituximab Bests Teriflunomide in Relapsing Multiple Sclerosis
WEDNESDAY, Aug. 31, 2022 (HealthDay News) — Patients with relapsing multiple sclerosis receiving ublituximab have lower annualized relapse rates and fewer brain lesions on magnetic resonance imaging than those receiving teriflunomide, according to a …
Learn MoreUn nuevo tratamiento para la EM se muestra promisorio en un ensayo
JUEVES, 25 de agosto de 2022 (HealthDay News) — Una terapia experimental de anticuerpos para la esclerosis múltiple (EM) puede reducir las exacerbaciones de síntomas a la mitad, en comparación con el tratamiento estándar, encontró un nuevo ensayo clí…
Learn MoreNew MS Treatment Shows Promise in Trial
THURSDAY, Aug. 25, 2022 (HealthDay News) — An experimental antibody therapy for multiple sclerosis can cut symptom flare-ups by half, versus a standard treatment, a new clinical trial has found.The drug, called ublituximab, beat a standard oral medic…
Learn MoreFactors Associated With Prevalence of Multiple Sclerosis Explored
THURSDAY, Aug. 25, 2022 (HealthDay News) — Variations in the prevalence of multiple sclerosis (MS) are at least partly due to sociodemographic, health systems, and neurology-specific factors, according to a study published online Aug. 24 in Neurology…
Learn MoreThere’s More MS in Northern Countries. Now, Researchers Find New Reason Why
THURSDAY, Aug. 25, 2022 (HealthDay News) — Vitamin D exposure, or lack of it, has long been thought to influence the risk of developing multiple sclerosis (MS) because the disease is diagnosed more often in people in northern countries. However, new …
Learn MoreRetinal Layer Thinning May Predict Relapse Remission in MS
THURSDAY, Aug. 18, 2022 (HealthDay News) — Retinal layer thinning after optic neuritis (ON) may be useful as a marker of future relapse remission in relapsing multiple sclerosis (MS), according to a study published online Aug. 2 in Neurology.Gabriel …
Learn MoreRisk Factors ID’d for Poor Health-Related QOL in MS Patients
FRIDAY, Aug. 12, 2022 (HealthDay News) — Early risk factors may predict health-related quality of life (HRQoL) for people with newly diagnosed multiple sclerosis (MS), according to a study published online Aug. 10 in Neurology.
Julia O’Mahony, Ph…
Learn MoreWho Fares Worse After Multiple Sclerosis Strikes?
THURSDAY, Aug. 11, 2022 (HealthDay News) — For people with multiple sclerosis, certain factors early in their disease may determine their quality of life in the years to come, a new study suggests.In medicine, there are ways to objectively measure a …
Learn More